Invaio Sciences Raises $88.9M in Series C Funding

Invaio Sciences

Invaio Sciences, Inc., a Cambridge, Mass.-based company focused on leveraging the planet’s interdependent natural systems to solve pressing agriculture, nutrition and environmental challenges, closed an $88.9m Series C financing round.

Joining founder and principal backer Flagship Pioneering is Stage 1 Ventures, Bluwave Capital, Alexandria Venture Investments, and others. With this financing, Invaio has raised more than $142m since its founding in 2018.

The company intends to use the funds to roll out solutions for problems including HLB in the citrus industry, Xylella in Olive production, and to institute more refined practices in managing vineyards and orchards.

Led by Ignacio Martinez, CEO, Gerardo Ramos, Chief Science Officer, and Peleg Chevion, President and Chief Commercial Officer, Invaio Sciences is a multi-platform technology company that leverages the planet’s interdependent systems to address pressing agricultural, nutritional, and environmental challenges.

The company has focused research and development in large addressable perennial, row crop and vegetable marketplaces. With this financing, Invaio will continue to focus on diverse areas of discovery including tree nutritional health, insect management, vector and disease control, transformative herbicides and fungicides replacements, advanced seed technologies, carbon cycling, and more.